Boston Common Asset Management LLC raised its position in Danaher Co. (NYSE:DHR – Get Rating) by 23.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 34,207 shares of the conglomerate's stock after buying an additional 6,452 shares during the quarter. Boston Common Asset Management LLC's holdings in Danaher were worth $8,835,000 as of its most recent filing with the SEC.
Several other institutional investors also recently bought and sold shares of DHR. Steward Financial Group LLC grew its stake in shares of Danaher by 330.4% during the 2nd quarter. Steward Financial Group LLC now owns 99 shares of the conglomerate's stock worth $25,000 after purchasing an additional 76 shares during the period. Goodman Advisory Group LLC acquired a new position in shares of Danaher during the 2nd quarter worth $27,000. Investors Asset Management of Georgia Inc. GA ADV acquired a new position in shares of Danaher during the 2nd quarter worth $32,000. Verity Asset Management Inc. acquired a new position in shares of Danaher during the 1st quarter worth $35,000. Finally, WFA of San Diego LLC acquired a new position in shares of Danaher during the 2nd quarter worth $35,000. 77.26% of the stock is owned by institutional investors and hedge funds.
Get Danaher alerts:Danaher Stock Performance
DHR stock opened at $260.20 on Tuesday. The stock has a market capitalization of $189.42 billion, a price-to-earnings ratio of 28.71, a PEG ratio of 2.06 and a beta of 0.83. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.38 and a current ratio of 1.78. Danaher Co. has a 1 year low of $233.71 and a 1 year high of $331.23. The stock's fifty day moving average is $260.58 and its two-hundred day moving average is $266.63.
Danaher (NYSE:DHR – Get Rating) last released its earnings results on Thursday, October 20th. The conglomerate reported $2.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.32. The firm had revenue of $7.66 billion for the quarter, compared to analyst estimates of $7.17 billion. Danaher had a return on equity of 18.33% and a net margin of 21.65%. Danaher's revenue was up 6.0% compared to the same quarter last year. During the same period in the previous year, the company earned $2.39 earnings per share. On average, research analysts predict that Danaher Co. will post 10.53 EPS for the current year.Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, December 30th will be given a dividend of $0.25 per share. The ex-dividend date is Thursday, December 29th. This represents a $1.00 dividend on an annualized basis and a yield of 0.38%. Danaher's payout ratio is presently 11.05%.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on DHR shares. Robert W. Baird lowered their price target on shares of Danaher from $325.00 to $315.00 and set an "outperform" rating on the stock in a research note on Friday, October 21st. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Danaher in a research report on Tuesday, December 13th. They issued a "buy" rating and a $310.00 price objective on the stock. Credit Suisse Group decreased their price objective on shares of Danaher to $315.00 in a research report on Thursday, October 27th. Barclays decreased their price objective on shares of Danaher from $285.00 to $277.00 and set an "overweight" rating on the stock in a research report on Tuesday, November 29th. Finally, Benchmark lowered shares of Danaher from a "buy" rating to a "hold" rating and set a $325.00 price objective on the stock. in a research report on Monday, October 24th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, Danaher has an average rating of "Moderate Buy" and a consensus target price of $310.15.
Insider Activity
In other news, Director Alan G. Spoon sold 500 shares of Danaher stock in a transaction dated Tuesday, October 25th. The stock was sold at an average price of $252.93, for a total transaction of $126,465.00. Following the completion of the sale, the director now directly owns 107,135 shares in the company, valued at approximately $27,097,655.55. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, SVP Georgeann Couchara sold 1,884 shares of the business's stock in a transaction that occurred on Tuesday, November 15th. The stock was sold at an average price of $271.61, for a total transaction of $511,713.24. Following the sale, the senior vice president now directly owns 2,588 shares in the company, valued at $702,926.68. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Alan G. Spoon sold 500 shares of the business's stock in a transaction that occurred on Tuesday, October 25th. The shares were sold at an average price of $252.93, for a total value of $126,465.00. Following the sale, the director now owns 107,135 shares in the company, valued at $27,097,655.55. The disclosure for this sale can be found here. Insiders sold a total of 39,038 shares of company stock worth $10,550,749 in the last three months. 11.20% of the stock is owned by insiders.
Danaher Profile
(Get Rating)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
Featured Articles
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- The Institutions Choose CarMax Over Carvana, Should You?
- Heatmap in Trading: How to Learn What Market Depth Hides
- Micron Technology Sees Chip Recovery by the End of 2023
- Three Healthcare Penny Stocks to Watch In The New Year
- Southwest Airlines Stock, There is a Lot to Love
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Get Rating).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.